The global radiopharmaceutical theranostics market is experiencing rapid expansion due to increasing adoption of precision oncology and targeted treatment approaches. The market is projected to grow from US$ 2.48 billion in 2025 to US$ 6.42 billion by 2034 , registering a robust CAGR of 11.14% during 2026–2034 . Radiopharmaceutical theranostics integrates diagnostic imaging and targeted...